Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixisenatide in older adults with type 2 diabetes inadequately controlled on current therapy
2012-003292-19Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of lixisenatide in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Apr 2013; status: completed.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2012-003292-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003292-19.